Stocks: Sectors
- Energy
- Materials
- Industrials
- Consumer Discretionary
- Consumer Staples
- Health Care
- Financial
- Technology
- Utilities
Futures
Benchmarks
Forex
Industries
Comparative
Seasonal Start
Economic Data
Halberd Corp. (OTCMKT:HALB) Seasonal Chart
Seasonal Chart Analysis
Analysis of the Halberd Corp. (OTCMKT:HALB) seasonal charts above shows that a Buy Date of November 28 and a Sell Date of March 1 has resulted in a geometric average return of 41.03% above the benchmark rate of the S&P 500 Total Return Index over the past 15 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 15 years by an average of 63.61% per year.
Halberd Corp. is a development stage company, which engages in the research and development of antibodies and devices for the prevention, detection, and treatment of neurodegenerative diseases. It offers patented extracorporeal treatment that is applicable to various blood-borne and neurologic diseases such as PTSD/ CTE (Post Traumatic Stress Disorder/Chronic Traumatic Encephalopathy), Alzheimer’s Disease, and Parkinson’s Disease. The company was founded by Mark Sven Lundquist and John Christopher Maddox on January 26, 2009 and is headquartered in Jackson Center, PA.
To download HALB seasonal chart data, please log in or Subscribe.
Stocks mentioned in this post: HALB
Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
|
|



